MATERNUS-Kliniken AG (DE:MAK)
XETRA:MAK
Holding DE:MAK?
Track your performance easily

MATERNUS-Kliniken AG (MAK) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
MATERNUS-Kliniken AG’s (MAK) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting MATERNUS-Kliniken AG is a Buy.
MATERNUS-Kliniken AG’s (MAK) 20-Day exponential moving average is 1.76, while MATERNUS-Kliniken AG’s (MAK) share price is €1.76, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) 50-Day exponential moving average is 1.76, while MATERNUS-Kliniken AG’s (MAK) share price is €1.76, making it a Buy.

MATERNUS-Kliniken AG (MAK) Pivot Points

Nov 05, 2024, 07:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.75
1.75
1.75
1.75
1.75
1.75
1.75
Fibonacci
1.75
1.75
1.75
1.75
1.75
1.75
1.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MATERNUS-Kliniken AG (MAK) Moving Averages

Nov 05, 2024, 07:20 AM
Period
Simple
Exponential
MA5
1.75Buy
1.76Buy
MA10
1.76Sell
1.76Buy
MA20
1.77Sell
1.76Sell
MA50
1.75Buy
1.76Buy
MA100
1.77Sell
1.80Sell
MA200
1.91Sell
2.01Sell
MATERNUS-Kliniken AG’s (MAK) 10-Day exponential moving average is 1.76, while MATERNUS-Kliniken AG’s (MAK) share price is €1.76, making it a Buy.
MATERNUS-Kliniken AG’s (MAK) 100-Day exponential moving average is 1.80, while MATERNUS-Kliniken AG’s (MAK) share price is €1.76, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.76 and MATERNUS-Kliniken AG’s (MAK) 50-day simple moving average is 1.75, creating a Buy signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.76 and MATERNUS-Kliniken AG’s (MAK) 100-day simple moving average is 1.77, creating a Sell signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.76 and MATERNUS-Kliniken AG’s (MAK) 200-day simple moving average is 1.91, creating a Sell signal.

MATERNUS-Kliniken AG (MAK) Technical Indicators

Nov 05, 2024, 07:20 AM
Name
Value
Implied Action
RSI (14)
49.66
Neutral
STOCH (9,6)
6.67
Buy
STOCHRSI (14)
22.22
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
13.65
Buy
Williams %R
-72.22
Buy
CCI (14)
-19.61
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
34.71
Neutral
ROC
1.15
Buy
MATERNUS-Kliniken AG’s (MAK) Relative Strength Index (RSI) is 49.66, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Trend Strength Indicator (ADX) is 13.65, creating a Buy signal.
MATERNUS-Kliniken AG’s (MAK) Commodity Channel Index (CCI) is -19.61, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Price Rate of Change (ROC) is 1.15, creating a Buy signal.

FAQ

Is MAK a Buy, Hold, or Sell?
Based on MAK’s technical indicators, MAK is a Hold.
    What is MAK’s RSI (14)?
    MAK’s RSI (14) is 49.66, which suggests MAK is a Neutral.
      What is MAK’s MACD?
      MAK’s MACD is >-0.01, which suggests MAK is a Buy.
        What is MAK’s 5-day moving average?
        MAK’s 5-day moving average is 1.75, which suggests MAK is a Buy.
          What is MAK’s 20-day moving average?
          MAK 20-day moving average is 1.77, which suggests MAK is a Sell.
            What is MAK’s 50-day moving average?
            MAK’s 50-day moving average is 1.75, which suggests MAK is a Buy.
              What is MAK’s 200-day moving average?
              MAK’s 200-day moving average is 1.91, which suggests MAK is a Sell.
                What is MAK’s Williams % R (14)?
                MAK’s Williams % R (14) is -72.22, which suggests MAK is a Buy.
                  What is MAK’s CCI (14)?
                  MAK’s CCI (14) is -19.61, which suggests MAK is a Neutral.
                    What is the share price of MATERNUS-Kliniken AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis